SWM
REGN icon

Sculati Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Sculati Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-754
Closed -$396K – 128
2025
Q2 		$396K Sell
754
-714
-49% -$399K 0.15% 93
2025
Q1 		$931K Sell
1,468
-485
-25% -$334K 0.38% 60
2024
Q4 		$1.39M Sell
1,953
-38
-2% -$31.9K 0.55% 49
2024
Q3 		$2.09M Sell
1,991
-18
-0.9% -$20K 0.83% 37
2024
Q2 		$2.11M Sell
2,009
-38
-2% -$36.8K 0.9% 41
2024
Q1 		$1.97M Buy
2,047
+15
+0.7% +$14.3K 0.85% 38
2023
Q4 		$1.78M Hold
2,032
– – 0.83% 40
2023
Q3 		$1.67M Sell
2,032
-112
-5% -$88K 0.85% 41
2023
Q2 		$1.54M Sell
2,144
-42
-2% -$32.4K 0.78% 44
2023
Q1 		$1.8M Sell
2,186
-13
-0.6% -$9.8K 0.95% 34
2022
Q4 		$1.59M Hold
2,199
– – 0.89% 35
2022
Q3 		$1.51M Sell
2,199
-10
-0.5% -$6.29K 0.89% 37
2022
Q2 		$1.31M Sell
2,209
-99
-4% -$64.4K 0.75% 51
2022
Q1 		$1.61M Buy
2,308
+110
+5% +$69.6K 0.79% 44
2021
Q4 		$1.39M Buy
2,198
+131
+6% +$80.5K 0.67% 46
2021
Q3 		$1.25M Buy
2,067
+105
+5% +$65.2K 0.66% 47
2021
Q2 		$1.1M Buy
1,962
+138
+8% +$69.9K 0.58% 53
2021
Q1 		$863K Buy
1,824
+553
+44% +$269K 0.5% 59
2020
Q4 		$614K Buy
1,271
+30
+2% +$16.2K 0.4% 62
2020
Q3 		$695K Buy
1,241
+308
+33% +$187K 0.52% 49
2020
Q2 		$582K Buy
+933
New +$530K 0.49% 55

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sculati Wealth Management's REGN Position: Q3 2025 in Review

Sculati Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 754 shares — an estimated $396K sold.

Sculati Wealth Management first reported a position in REGN in Q2 2020 and held it in 21 quarters. The position peaked at $2.11M in Q2 2024. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Sculati Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Sculati Wealth Management sold 754 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $396K.
  • Sculati Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2020 and held it in 21 quarters.
  • Sculati Wealth Management's Regeneron Pharmaceuticals position peaked at $2.11M in Q2 2024.
  • 1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Sculati Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.